SUBSTITUTED HETEROCYCLIC COMPOUNDS AND THEIR USE AS RETINOID-RELATED ORPHAN RECEPTOR (ROR) GAMMA-T INHIBITORS

The present invention relates to the field of (auto)immune diseases. The present invention provides heterocyclic compounds having an ROR-yt inhibitory action. It also provides for the use of the compounds as a medicament, in particular for use in the treatment of (auto)immune diseases. Also provided...

Full description

Saved in:
Bibliographic Details
Main Authors BRUNSVELD, Lucas, SCHEEPSTRA, Marcel, MILROY, Lech-Gustav, DOVESTON, Richard Gerard, LEYSEN, Seppe Frans Roman, OTTMANN, Christian, MEIJER, Femke Anouk
Format Patent
LanguageEnglish
Published 16.12.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the field of (auto)immune diseases. The present invention provides heterocyclic compounds having an ROR-yt inhibitory action. It also provides for the use of the compounds as a medicament, in particular for use in the treatment of (auto)immune diseases. Also provided are pharmaceutical compositions comprising the compounds having ROR-yt inhibitory action.
Bibliography:Application Number: US202017422645